Callahan Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.4M | Buy |
103,082
+12,169
| +13% | +$937K | 0.62% | 46 |
|
|
2025
Q4 | $7.21M | Buy |
90,913
+2,105
| +2% | +$166K | 0.59% | 47 |
|
|
2025
Q3 | $6.7M | Buy |
88,808
+12,158
| +16% | +$833K | 0.57% | 51 |
|
|
2025
Q2 | $5.29M | Buy |
76,650
+44,285
| +137% | +$2.9M | 0.48% | 58 |
|
|
2025
Q1 | $2.19M | Buy |
32,365
+3,117
| +11% | +$187K | 0.21% | 87 |
|
|
2024
Q4 | $1.31M | Sell |
29,248
-4,886
| -14% | -$274K | 0.12% | 96 |
|
|
2024
Q3 | $2.15M | Sell |
34,134
-11,638
| -25% | -$679K | 0.21% | 82 |
|
|
2024
Q2 | $2.7M | Sell |
45,772
-25,651
| -36% | -$1.6M | 0.28% | 73 |
|
|
2024
Q1 | $5.7M | Buy |
71,423
+1,002
| +1% | +$76.5K | 0.6% | 53 |
|
|
2023
Q4 | $5.56M | Buy |
70,421
+1,691
| +2% | +$120K | 0.65% | 52 |
|
|
2023
Q3 | $4.8M | Sell |
68,730
-32,309
| -32% | -$2.29M | 0.6% | 52 |
|
|
2023
Q2 | $6.98M | Buy |
101,039
+12,935
| +15% | +$920K | 0.85% | 42 |
|
|
2023
Q1 | $6.55M | Sell |
88,104
-3,633
| -4% | -$305K | 0.85% | 45 |
|
|
2022
Q4 | $8.55M | Buy |
91,737
+1,805
| +2% | +$174K | 1.17% | 34 |
|
|
2022
Q3 | $8.58M | Buy |
89,932
+1,687
| +2% | +$167K | 1.23% | 31 |
|
|
2022
Q2 | $8.18M | Sell |
88,245
-2,427
| -3% | -$237K | 1.09% | 37 |
|
|
2022
Q1 | $9.18M | Sell |
90,672
-14,375
| -14% | -$1.51M | 1.05% | 37 |
|
|
2021
Q4 | $10.8M | Buy |
105,047
+1,489
| +1% | +$138K | 1.22% | 31 |
|
|
2021
Q3 | $8.79M | Buy |
103,558
+858
| +0.8% | +$71.9K | 1.11% | 35 |
|
|
2021
Q2 | $8.57M | Buy |
102,700
+2,719
| +3% | +$223K | 1.09% | 36 |
|
|
2021
Q1 | $7.52M | Buy |
99,981
+4,286
| +4% | +$312K | 1.02% | 39 |
|
|
2020
Q4 | $6.54M | Buy |
95,695
+3,821
| +4% | +$249K | 0.96% | 39 |
|
|
2020
Q3 | $5.37M | Sell |
91,874
-1,763
| -2% | -$110K | 0.88% | 42 |
|
|
2020
Q2 | $6.08M | Buy |
93,637
+13,777
| +17% | +$868K | 1.08% | 37 |
|
|
2020
Q1 | $4.74M | Buy |
79,860
+16,960
| +27% | +$1.13M | 0.99% | 38 |
|
|
2019
Q4 | $4.67M | Buy |
62,900
+18,288
| +41% | +$1.28M | 0.75% | 50 |
|
|
2019
Q3 | $2.81M | Buy |
44,612
+12,429
| +39% | +$737K | 0.49% | 55 |
|
|
2019
Q2 | $1.75M | Buy |
32,183
+2,960
| +10% | +$159K | 0.31% | 67 |
|
|
2019
Q1 | $1.58M | Buy |
29,223
+6,115
| +26% | +$377K | 0.29% | 69 |
|
|
2018
Q4 | $1.51M | Buy |
23,108
+2,377
| +11% | +$177K | 0.32% | 68 |
|
|
2018
Q3 | $1.63M | Buy |
20,731
+85
| +0.4% | +$6.08K | 0.3% | 72 |
|
|
2018
Q2 | $1.33M | Buy |
20,646
+1,803
| +10% | +$119K | 0.26% | 75 |
|
|
2018
Q1 | $1.17M | Buy |
18,843
+805
| +4% | +$57.8K | 0.24% | 77 |
|
|
2017
Q4 | $1.31M | Sell |
18,038
-8,329
| -32% | -$606K | 0.26% | 75 |
|
|
2017
Q3 | $2.14M | Sell |
26,367
-8,153
| -24% | -$645K | 0.45% | 58 |
|
|
2017
Q2 | $2.78M | Sell |
34,520
-9,721
| -22% | -$768K | 0.6% | 51 |
|
|
2017
Q1 | $3.47M | Sell |
44,241
-7,482
| -14% | -$597K | 0.78% | 47 |
|
|
2016
Q4 | $4.08M | Sell |
51,723
-4,014
| -7% | -$325K | 0.98% | 40 |
|
|
2016
Q3 | $4.96M | Sell |
55,737
-4,708
| -8% | -$444K | 1.24% | 35 |
|
|
2016
Q2 | $5.79M | Sell |
60,445
-7,419
| -11% | -$739K | 1.52% | 30 |
|
|
2016
Q1 | $7.04M | Buy |
67,864
+1,473
| +2% | +$143K | 1.93% | 22 |
|
|
2015
Q4 | $6.49M | Sell |
66,391
-932
| -1% | -$91.3K | 1.85% | 19 |
|
|
2015
Q3 | $6.5M | Buy |
67,323
+1,684
| +3% | +$177K | 1.99% | 17 |
|
|
2015
Q2 | $6.88M | Sell |
65,639
-1,017
| -2% | -$104K | 1.98% | 15 |
|
|
2015
Q1 | $6.88M | Buy |
66,656
+1,486
| +2% | +$150K | 2.01% | 12 |
|
|
2014
Q4 | $6.28M | Sell |
65,170
-1,092
| -2% | -$96.2K | 1.85% | 14 |
|
|
2014
Q3 | $5.27M | Buy |
66,262
+704
| +1% | +$55.5K | 1.63% | 20 |
|
|
2014
Q2 | $4.94M | Buy |
65,558
+864
| +1% | +$65.3K | 1.57% | 22 |
|
|
2014
Q1 | $4.84M | Buy |
64,694
+444
| +0.7% | +$31.4K | 1.65% | 21 |
|
|
2013
Q4 | $4.6M | Sell |
64,250
-790
| -1% | -$50.8K | 1.6% | 22 |
|
|
2013
Q3 | $3.69M | Buy |
65,040
+933
| +1% | +$55.6K | 1.41% | 29 |
|
|
2013
Q2 | $3.67M | Buy |
+64,107
| New | +$3.71M | 1.5% | 24 |
|
Other funds holding CVS
VCM
VPM
Callahan Advisors's CVS Position: Q1 2026 in Review
Callahan Advisors increased its CVS Health (CVS) stake by 13% in Q1 2026, buying an estimated $937K and bringing the position to 103,082 shares worth $7.4M. The position accounts for 0.62% of the portfolio, ranked #46.
Callahan Advisors first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.8M in Q4 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Callahan Advisors held 103,082 shares of CVS Health worth $7.4M as of Q1 2026.
- Callahan Advisors bought 12,169 CVS Health shares in Q1 2026, an estimated $937K.
- CVS Health made up 0.62% of Callahan Advisors's portfolio in Q1 2026, its #46 holding.
- Callahan Advisors first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
- Callahan Advisors's CVS Health position peaked at $10.8M in Q4 2021.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Callahan Advisors's 13F filing for Q1 2026, filed 12 May 2026.